Antithrombotic therapy (aspirin, P2Y12 inhibitor, heparin) was carefully balanced to prevent stent thrombosis without causing hemorrhage, with no major bleeding or stroke hemorrhagic conversion occurring. Here, P2RY12 is linked to stroke disorder.